Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study

Edinburgh Type 2 Diabetes Study investigators, Joanne R Morling, Jonathan A Fallowfield, Indra N Guha, Lisa D Nee, Stephen Glancy, Rachel M Williamson, Christine M Robertson, Mark W J Strachan, Jackie F Price

Research output: Contribution to journalArticlepeer-review

Abstract

It is difficult to determine the different stages of non-alcoholic fatty liver disease without the use of invasive liver biopsy. In this study we investigated five non-invasive biomarkers used previously to detect hepatic fibrosis and determined the level of agreement between them in order to inform future research.
Original languageEnglish
JournalJournal of Hepatology
DOIs
Publication statusPublished - 25 Oct 2013

Fingerprint Dive into the research topics of 'Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study'. Together they form a unique fingerprint.

Cite this